Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Utility of Optical Genome Mapping as an Additional Tool in a Standard Cytogenetic Workup in Hematological Malignancies

25 Apr 2025

Abstract excerpt

BACKGROUND AND OBJECTIVE: The primary objective of this study is to evaluate the added value of optical genome mapping (OGM) when integrated into the standard cytogenetic workup (SCGW) for hematological malignancies. METHODS: The study cohort comprised 519 cases with different types of hematological malignancies. OGM and SCGW (including G-banded karyotyping and fluorescence in situ hybridization) were performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Genomic variations and chromosomal abnormalities

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40361363
DOI: 10.3390/cancers17091436

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Utility of Optical Genome Mapping as an Additional Tool in a Standard Cytogenetic Workup in Hematological MalignanciesPMID 40361363Read ↗

Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNASemantic proximity Read ↗

Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mappingSemantic proximity Read ↗

Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemiaSemantic proximity Read ↗

Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological NeoplasmsSemantic proximity Read ↗

Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML / MDS patientsSemantic proximity Read ↗

Analytic Validation of Optical Genome Mapping in Hematological MalignanciesSemantic proximity Read ↗

Clinical Validation of Optical Genome Mapping for the Detection of Structural Variations in Hematological MalignanciesSemantic proximity Read ↗

Application of Optical Genome Mapping for the Diagnosis and Risk Stratification of Myeloid and Lymphoid MalignanciesSemantic proximity Read ↗

Optical Genome Mapping: Clinical Validation and Diagnostic Utility for Enhanced Cytogenomic Analysis of Hematological NeoplasmsSemantic proximity Read ↗

Optical genome mapping for structural variation analysis in hematologic malignanciesSemantic proximity Read ↗

Optical genome mapping in acute myeloid leukemia: a multicenter evaluationSemantic proximity Read ↗

Optical genome mapping refines cytogenetic diagnostics, prognostic stratification and provides new molecular insights in adult MDS/AML patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.